3.74
price up icon3.31%   0.12
after-market Handel nachbörslich: 3.74
loading

Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten

pulisher
Jun 18, 2025

enGene Holdings: Looking For An End To The 2025 Decline (Downgrade) (NASDAQ:ENGN) - Seeking Alpha

Jun 18, 2025
pulisher
Jun 17, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) to four newly-hired employees - BioSpace

Jun 17, 2025
pulisher
Jun 17, 2025

enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Jun 17, 2025
pulisher
Jun 16, 2025

JMP reiterates market outperform rating on enGene stock on clinical progress By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

JMP reiterates market outperform rating on enGene stock on clinical progress - Investing.com Australia

Jun 16, 2025
pulisher
Jun 16, 2025

Engene stock maintains buy rating at H.C. Wainwright on LEGEND trial - Investing.com

Jun 16, 2025
pulisher
Jun 14, 2025

enGene Holdings Inc. adopts new employee stock plan By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 12, 2025

enGene Holdings Reports Q2 2025 Financial Results - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Engene stock maintains Outperform rating at Raymond James on strong execution By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Engene stock maintains Outperform rating at Raymond James on strong execution - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

EnGene Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2025 - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Holdings Inc reports results for the quarter ended April 30Earnings Summary - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

EnGene Reports Second Quarter 2025 Financial Results And Provides Business Update - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

enGene Holdings Inc. SEC 10-Q Report - TradingView

Jun 12, 2025
pulisher
Jun 11, 2025

enGene Holdings CMO Resignation Announced - MSN

Jun 11, 2025
pulisher
Jun 10, 2025

enGene Holdings Approves 2025 Employee Stock Purchase Plan - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

enGene Holdings Inc. adopts new employee stock plan - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

ENGENE HOLDINGS Earnings Preview: Recent $ENGN Insider Trading, Hedge Fund Activity, and More - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

enGene Holdings Expands with New Boston Lease - TipRanks

Jun 09, 2025
pulisher
Jun 07, 2025

(ENGN) On The My Stocks Page - news.stocktradersdaily.com

Jun 07, 2025
pulisher
Jun 05, 2025

enGene CMO Dr. Raj Pruthi to step down mid-June By Investing.com - Investing.com India

Jun 05, 2025
pulisher
Jun 04, 2025

EnGene Chief Medical Officer Raj Pruthi to Step Down - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

enGene CMO Dr. Raj Pruthi Resigns - citybiz

Jun 04, 2025
pulisher
Jun 04, 2025

enGene (ENGN) CMO Raj Pruthi Steps Down | ENGN Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

enGene CMO Dr. Raj Pruthi to step down mid-June - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

enGene Announces the Resignation of its Chief Medical Officer - Business Wire

Jun 04, 2025
pulisher
May 29, 2025

enGene to Present at the Jefferies Global Healthcare Conference - BioSpace

May 29, 2025
pulisher
May 29, 2025

enGene appoints new Chief Global Commercialization Officer By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

enGene Names Amy Pott as Chief Global Commercialization Officer - citybiz

May 28, 2025
pulisher
May 28, 2025

enGene appoints new Chief Global Commercialization Officer - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

enGene (ENGN) Appoints Amy Pott as New Chief Global Commercialization Officer | ENGN Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

EnGene Names Amy Pott As Chief Global Commercialization Officer - marketscreener.com

May 28, 2025
pulisher
May 27, 2025

When (ENGN) Moves Investors should Listen - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Head-To-Head Review: enGene (NASDAQ:ENGN) vs. ImmunityBio (NASDAQ:IBRX) - Defense World

May 27, 2025
pulisher
May 17, 2025

Where are the Opportunities in (ENGN) - news.stocktradersdaily.com

May 17, 2025
pulisher
May 08, 2025

Is enGene Holdings (NASDAQ:ENGN) Using Too Much Debt? - simplywall.st

May 08, 2025
pulisher
May 06, 2025

(ENGN) Trading Signals - news.stocktradersdaily.com

May 06, 2025
pulisher
Apr 29, 2025

Citizens JMP reiterates Engene stock with $18 target By Investing.com - Investing.com Nigeria

Apr 29, 2025
pulisher
Apr 29, 2025

Citizens JMP reiterates Engene stock with $18 target - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

enGene to Participate in Upcoming Investor Conferences - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

enGene to Participate in Upcoming May 2025 Investor Conferences - BioSpace

Apr 29, 2025
pulisher
Apr 27, 2025

enGene Holdings Inc.'s (NASDAQ:ENGN) largest shareholders are private equity firms with 38% ownership, institutions own 35% - Yahoo Finance

Apr 27, 2025
pulisher
Apr 23, 2025

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now? - Insider Monkey

Apr 23, 2025
pulisher
Apr 21, 2025

(ENGN) Technical Data - news.stocktradersdaily.com

Apr 21, 2025
pulisher
Apr 14, 2025

enGene (NASDAQ:ENGN) & Innate Pharma (OTCMKTS:IPHYF) Head-To-Head Survey - Defense World

Apr 14, 2025
pulisher
Apr 10, 2025

enGene Holdings Inc. (NASDAQ:ENGN) Receives Average Rating of “Buy” from Analysts - Defense World

Apr 10, 2025
pulisher
Apr 05, 2025

Trend Tracker for (ENGN) - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 04, 2025

Engene Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com

Apr 04, 2025
pulisher
Apr 04, 2025

enGene Expands Team with New Hires, Grants 144,650 Shares in Stock Options - Stock Titan

Apr 04, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):